Elizabeth Weise, Indianapolis Star

Elizabeth Weise

Indianapolis Star

San Francisco, CA, United States

Contact Elizabeth

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Indianapolis Star
  • North Jersey News
  • Enquirer
  • Salina Journal
  • CJOnline
  • DelmarvaNow!
  • Detroit Free Press
  • Tallahassee Democrat
  • A-J Media
  • The Progress-Index
  • The News Leader
  • Burlington TimesNews
  • El Paso Times
  • Lansing StateJournal
  • and more…

Recent articles by Elizabeth:

FDA committee moves Pfizer-BioNTech COVID-19 vaccine closer to use for children ages 5-11

In children ages 5-11, the Pfizer-BioNTech vaccine was more than 90% protective against contracting symptomatic COVID-19, according to company data. → Read More

Pick any vaccine: CDC OKs COVID boosters – even mixing and matching – beginning as soon as Friday

Americans are now free to get a free booster dose of all three COVID-19 vaccines. The CDC has OK'd mixing and matching vaccines, too. → Read More

CDC advisory panel clears the way for J&J, Moderna and mix-and-match COVID boosters

Quick approval by the CDC director is expected, allowing J&J, Moderna and mix-and-match boosters to be given within days. → Read More

CDC advisory panel to review FDA's decision on Moderna, J&J booster shots: COVID-19 updates

A federal committee is expected to vote Thursday on whether to allow booster shots for the Moderna and Johnson & Johnson COVID vaccines. More updates. → Read More

FDA OKs mixing COVID vaccine boosters, backs Moderna, J&J boosters

The CDC still needs to sign off on the measure before booster shots of the Moderna and Johnson and Johnson vaccines become available. → Read More

FDA panel supports J&J COVID-19 vaccine booster shot for all Americans who got a first dose

In an unanimous vote, a federal advisory committee supported boosters of the J&J vaccine for all adults at least two months after a single shot. → Read More

FDA panel supports Moderna COVID-19 booster shots for older Americans and other adults at higher risk of infection

The Moderna COVID booster shot will be a half-dose of the vaccine already given. Data showed it was safe and just as effective at the lower dose. → Read More

COVID-19 herd immunity is a mirage. Here's how the virus could become 'manageable' instead.

Reinfections, the delta variant and waning vaccine immunity mean eradicating COVID may be impossible. Here's what living with the virus might be like. → Read More

More than 20M Americans are eligible for Pfizer-BioNTech booster shots. Should you get one?

More than 20 million Americans are now eligible for the booster shots, including those over 65 and many with underlying conditions. → Read More

CDC endorses COVID-19 vaccine boosters for people 65 and older, high-risk patients

The CDC endorsed booster shots for millions of older and high-risk Americans, opening a major new phase in the U.S vaccination drive against COVID-19. → Read More

Who should get COVID-19 boosters first? CDC committee set to vote Thursday – but only on Pfizer vaccine

Among the more than 20,000 people who have been tracked after receiving a third dose, no major safety concerns have popped up, CDC officials say. → Read More

FDA panel approves Pfizer-BioNTech COVID-19 booster shots only for people 65 and older or at high risk

There isn’t yet sufficient evidence to support boosters for people under 65, the FDA Vaccines and Related Biological Products Advisory Committee said. → Read More

Who will be able to get a COVID-19 booster shot and when? That's still in limbo.

As early as Sept. 20, third doses of the COVID-19 vaccine are set to become available. But guidance will come down to the wire to meet Biden's goal. → Read More

It's not easy to pronounce. But one thing is certain about FDA-approved Comirnaty: It works

The FDA issued full authorization for the Pfizer-BioNTech COVID-19 vaccine. Soon, millions of Americans will wonder: How do you pronounce Comirnaty? → Read More

Pfizer's COVID-19 vaccine becomes first to win FDA's full approval, paving way for boosters, mandates

The FDA's decision to fully license Pfizer's COVID-19 vaccine is expected to trigger more vaccination mandates and allow marketing of the shot. → Read More

'Miserable' breakthrough COVID-19 cases are increasing, but experts aren't sure how common they are

Breakthrough infections of COVID-19 among the vaccinated are rising, even as the vaccine continues to protect against severe disease and death. → Read More

White House plans to authorize COVID-19 booster shoots for most Americans, but some experts have their doubts

The Biden administration is expected as soon as this week to recommend most Americans get a COVID-19 booster shot. Some experts have their doubts. → Read More

Would you get the COVID-19 vaccine if the Pope asked you to? He calls it 'an act of love.'

Pope Francis and six Catholic cardinals and archbishops made a public service announcement in which they urged people to get a COVID-19 vaccine. → Read More

Biden administration expected to recommend COVID booster shots for all Americans amid case surge

Biden administration health officials are expected to recommend COVID-19 booster shots for all Americans 8 months after they received the second shot. → Read More

New COVID cases in US soar 700% week-over-week since July 1, CDC says

Since July 1, there's been a 700% increase in 7-day rolling average of COVID-19 infections in U.S., according to the Centers for Disease Control and Prevention. → Read More